Social Media Ideas for Best In Biotech

Best Workplaces for Innovators 2026: Biotech, healthcare, and life sciences category winners

Of the 10 companies earning top honors from Fast Company judges in the biotech, healthcare, and life sciences fields category of Best Workplaces for Innovators 2026, half are in th...

This week in charts: Biotech’s rebound is undeniable

Not only is the XBI continuing to hover around a historic high, but drug companies can’t seem to get enough of both large IPOs and big-ticket M&A.

<![CDATA[Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTe...

SA Asks: What are the most promising oncology companies right now?

Are Biotech Stocks The 'Comeback Kid' Of 2026? I Say Yes

From confidence to capital: Positioning biotech for the next growth cycle

How can biotechs be investor ready? Key takeaways from BIO International and DIA China 2026.

Biotech remains compelling even after major comeback. Here’s what investors say

The healthcare subsector has quietly become one of the most attractive opportunities this year.

10 biotechs in Japan to watch in 2026 

While Japan historically lacked foreign investment, the field is becoming more dynamic. Discover ten essential biotech companies in Japan. The post 10 biotechs in Japan to watch in...

Biopharma’s Drawdown Is a Chance to Build Biotech Back Better

American biotechnology hubs like Boston, Seattle, and San Diego are starting to wake up again. But will they be able to learn from the lessons of the recent past? The post Biopharm...

With $263M, LifeMine unearths a new drug for organ transplants

Led by serial biotech entrepreneur Greg Verdine, the startup mined fungi genomes to find a safer alternative to the drugs widely used to prevent the body from rejecting transplante...

The State of Biotech 2026

The world of biotech is showing strong signs of growth and clinical impact while also experiencing new challenges. The explosion of AI is reshaping areas from drug discovery and pr...

The biggest biotech funding rounds in August 2026

The companies Moderna, Amylyx Pharmaceuticals, and Braveheart Bio bagged the biggest biotech funding rounds overall in August 2026. The post The biggest biotech funding rounds in A...

<![CDATA[The Status of Nuvation Bio’s Pipeline]]>

Indiana Emerges as a Leading U.S. Biopharma Hub

Indiana has spent decades becoming a national leader in life sciences and pharmaceutical exports. Its strengths extend across universities, research institutes, manufacturers, supp...

5 emerging biotech hubs

Boston. San Francisco. Beijing? The global biotech industry has long been concentrated in a handful of cities. But which emerging hubs could become dominant forces in biotech in th...

Thermo Fisher Scientific: Biopharma Recovery And Share Gains Support The Upside

Next 10 U.S. Biopharma Clusters

For the first time, GEN's Alex Philippidis examines the top regions and top states just below the 10 largest regions for life sciences activity, as the field looks beyond the East...

From Molecule to Market: Life Sciences AI Enters Governed Production

Black Book Research and Applied Artificial Intelligence LLC identify 2026-2027 client-rated technology leaders across 28 pharmaceutical, biotechnology and life sciences markets bas...

<![CDATA[M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to...

Eldex Corporation Strengthens Long-Term Scientific Engagement Through Continued Partnership with Bioz

‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D wins

A string of recent wins on the frontiers of novel drug development could mean that a homegrown innovation industry is within reach.

The biggest biotech funding rounds in July 2026

The companies BridgeBio, Erasca, Chai Discovery, and MeiraGTx bagged the biggest biotech funding rounds overall in July 2026. The post The biggest biotech funding rounds in July 20...

Bioz and InvivoGen Elevate Scientific Discovery with an Expanded Digital Research Experience

Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?

They could both outperform the market over the medium term, but one appears to have a clear edge.